US company Moderna's Covid-19 vaccine is getting successful in its first trial. Research in the New England Journal of Medicine reported that 45 people recovered. The results of the first test of this drug have been prolific. This drug developed antibodies to rust from Covid-19 within everyone.

Another special feature of Moderna's medicine is that it has no such distinct side effect, due to which the test of vaccine is stopped. If the antibody is formed in the initial testing, it is considered to be a huge success but it does not mean that the drug would be effective in eradicating the coronavirus. This first trial included 45 people who were well and aged between 18 and 55 years old.

At the time of this test, the drug was also tested on the elderly, whose results have not yet come. Vaccine manufacturer Moderna is now preparing for the late-stage trial of the drug Covid-1. Moderna said that it will conduct a trial of this drug at 87 study locations in the US. It is being speculated that the company can make a big announcement after the third stage trial is successful. The vaccine will be available in the market as soon as possible.

117th Birth Anniversary: Stalwart leader K. Kamaraj played leading role in shaping India

Corona wreaks havoc in Brazil, many new cases surfaced

Another meeting between Nepal PM KP Oli and Executive President Prachanda cancelled